IP Library Granted Patent US 9,752,176
Granted Patent B2
US 9,752,176 · App. 13/524,164 · Granted Sep 5, 2017

Methods for preparative in vitro cloning

Inventors: Li-yun A. Kung (Arlington, MA); Daniel Schindler (Newton, MA); Joseph Jacobson (Newton, MA)
Assignee: Ginkgo Bioworks, Inc.
C12Q1/6806C12Q1/6855C12Q2525/191C12Q2533/107
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,752,176
App. No.
13/524,164
Filed
Jun 15, 2012
Granted
Sep 5, 2017
Kind
B2
Art Unit
1637
USPC
435/6.11
Abstract

Methods and devices relate to the isolation of nucleic acids of interest from within a population of nucleic acids such as libraries of nucleic acid sequences.

Claims (40)

1. A method of isolating a target nucleic acid molecule, the method comprising:

(a) providing a plurality of nucleic acid molecules;

(b) providing a library of oligonucleotide tags, each oligonucleotide tag comprising a region having a different sequence than the other tags in the library and comprising a primer binding site;

(c) ligating at least a subset of the plurality of nucleic acid molecules with the library of oligonucleotide tags, thereby generating a population of conjugates, wherein each conjugate has a unique oligonucleotide tag that is different in sequence than that of the other conjugates;

(d) amplifying in a pool at least a subset of the population of conjugates using one or more primers each having sequence complementarity to the primer binding site thereon;

(e) isolating at least one conjugate of the amplified conjugates from the pool, wherein the isolated conjugate comprises a target nucleic acid molecule having a predetermined sequence; and

(f) removing the oligonucleotide tag attached thereto to recover the target nucleic acid molecule.

2. The method of claim 1 further comprising sequencing the amplified conjugates.

3. The method of claim 2 wherein the sequencing step comprises high throughput sequencing.

4. The method of claim 2 wherein the step of isolating comprises clonally separating the target nucleic acid molecule from non-target by selectively amplifying, after the sequencing step, at least one conjugates.

5. The method of claim 1 wherein the step of isolating comprises limiting dilution.

6. The method of claim 5 further comprising amplifying the isolated conjugate.

7. A method of isolating a target nucleic acid molecule, the method comprising:

(a) providing a population of nucleic acid molecules having different predetermined sequences;

(b) providing a plurality of oligonucleotide sequences that are different from one another in sequence and are immobilized on microparticles, each microparticle having a single copy of oligonucleotide sequence immobilized on its surface, wherein each single copy of oligonucleotide sequence is uniquely complementary to a corresponding nucleic acid molecule of the population;

(c) hybridizing the population of nucleic acid molecules to the plurality of oligonucleotide sequences, thereby forming a population of hybridized microparticles, each hybridized microparticle having a single nucleic acid molecule attached thereon via hybridization with its corresponding uniquely complementary oligonucleotide sequence;

(d) separating the population of hybridized microparticles into samples, each sample comprising a single hybridized microparticle; and

(e) isolating at least one hybridized microparticle comprising a target nucleic acid molecule having a predetermined sequence.

8. The method of claim 7 wherein each nucleic acid molecule comprises an oligonucleotide tag at one terminus.

9. The method of claim 8 wherein the plurality of nucleic acid molecules have the same oligonucleotide tag.

10. The method of claim 8 wherein the plurality of nucleic acid molecules have different oligonucleotide tags.

11. The method of claim 7 wherein the step of isolating comprises limiting dilution.

12. The method of claim 7 further comprising amplifying the target nucleic acid molecule.

13. The method of claim 1 wherein the step of amplifying comprises providing a plurality of primers in stoichiometry wherein the absolute number of primers is less than the absolute number of oligonucleotide tags.

14. The method of claim 1 wherein in the step of providing a library of oligonucleotide tags, each oligonucleotide tag in the library differs from one another by at least 2 nucleotides.

15. The method of claim 1 wherein step (d) is performed in solution.

16. The method of claim 1 wherein in step (b), the library of oligonucleotide tags is provided in stoichiometry wherein the absolute number of oligonucleotide tags is less than the absolute number of nucleic acid molecules.

17. The method of claim 1 further comprising isolating a plurality of target nucleic acid molecules having different predetermined sequences and assembling the plurality of target nucleic acid molecules.

18. The method of claim 1 wherein in step (a) the nucleic acid molecules are synthesized on a solid support.

19. A method of isolating a target nucleic acid molecule, the method comprising:

(a) providing a population of nucleic acid conjugates, each having a distinct predetermined sequence and a oligonucleotide tag that is different in sequence than that of the other conjugates, wherein each predetermined sequence and each oligonucleotide tag are conjugated via ligation;

(b) amplifying in a pool at least a subset of the population of nucleic acid conjugates using primers having sequence complementarity to the oligonucleotide tags conjugated thereto;

(c) isolating a target nucleic acid molecule having a predetermined sequence from the amplified nucleic acid molecules in the pool; and

(d) removing the oligonucleotide tag conjugated thereto to recover the target nucleic acid molecule.

20. The method of claim 1 , wherein the removing step (f) comprises contacting the isolated conjugate with an endonuclease to produce a double-stranded break.

21. The method of claim 20 further comprising isolating a plurality of target nucleic acid molecules having different predetermined sequences that together comprise and can be assembled into a target polynucleotide.

22. The method of claim 1 , wherein the removing step (f) comprises selectively amplifying the target nucleic acid molecule.

23. The method of claim 19 , wherein the removing step (d) comprises contacting the isolated target nucleic acid molecule with an endonuclease to produce a double-stranded break.

24. The method of claim 23 further comprising isolating a plurality of target nucleic acid molecules having different predetermined sequences that together comprise and can be assembled into a target polynucleotide.

25. The method of claim 19 , wherein the removing step (d) comprises selectively amplifying the target nucleic acid molecule.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2025
From: GINKGO BIOWORKS, INC.
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 072092/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2025
From: GEN9, INC.
To: GINKGO BIOWORKS, INC.
Reel/Frame 071945/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2012
From: KUNG, LI-YUN A.; SCHINDLER, DANIEL; JACOBSON, JOSEPH
To: GEN9, INC.
Reel/Frame 028749/0881 →
Continuity (2)
Provisional Application 61497506 · Jun 15, 2011
Related Publication 20120322681A1 · Dec 20, 2012